首页 > 最新文献

Gynecology and Obstetrics Clinical Medicine最新文献

英文 中文
Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions 宫颈病变中人类乳头瘤病毒基因型分布和流行情况的全面概述
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.1136/gocm-2024-000005
Yuhong Ye, Terrel Jones, Tiannan Wang, Xianxu Zeng, Yang Liu, Chengquan Zhao
Across cervical squamous and glandular lesions, a spectrum of human papillomavirus (HPV) genotypes has been identified. This review aims to provide a comprehensive summary detailing the distribution and profile of HPV genotypes detected in cervical lesions, leveraging insights from histological and cytological findings. High-risk HPV (HR-HPV) genotypes exhibit varying degrees of oncogenic potential, with HPV16 and HPV18 identified as the most prevalent and oncogenic types. The distribution of HR-HPV genotypes varies among different degrees of the cervical lesions and varies between squamous and glandular neoplasia. HPV16 is predominantly associated with severe lesions (precancers and carcinomas), while HPV18 demonstrates a significantly higher prevalence in endocervical as compared with squamous neoplasia. The distribution of HR-HPV in severe squamous lesions is complex, involving many HR-HPV genotypes in addition to HPV16, while the distribution of HR-HPV genotypes in endocervical glandular lesions is mainly limited in HPV18 and HPV16. Large datasets from China have identified the three most common HR-HPV genotypes in this population as stratified by diagnostic category: HPV52, HPV16, HPV58 in histologically negative cases and cervical intraepithelial neoplasia 1 (CIN1); HPV16, HPV52, HPV58 in CIN2/3; HPV16, HPV58, HPV52 or HPV18 in squamous cell carcinoma (SCC); HPV16, HPV18 and HPV52 in endocervical adenocarcinoma in situ (AIS), invasive adenocarcinoma, as well as mixed squamous and glandular lesions. HPV33 is the fourth most common HPV type in CIN2/3 and SCC, while HPV45 occurs more commonly in AIS and adenocarcinoma, compared with squamous lesions. The prevalence and distribution of multiple HR-HPV coinfections vary across different cervical diseases. The clinical significance and pathogenesis of these multiple HR-HPV infections remain uncertain, although recent two large studies demonstrate that multiple HR-HPV infections are not associated with cumulatively higher risk of high-grade cervical squamous lesion development, suggesting competitive and/or cooperative interactions among HPV genotypes. Extensive HPV genotyping aids in risk assessment and optimising clinical approaches for women with mild abnormalities in Pap cytology. Women with atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) Pap test results and with the infection of some HR-HPV genotypes carry a very low risk of high-grade cervical lesions. HPV genotyping can allow for risk stratification and triage optimisation for these HR-HPV-positive women. Women with atypical glandular cell (AGC) Pap test results showed a specific HPV genotyping pattern and extended HPV genotyping may be helpful for the clinical management of AGCs. Continual advancements in clinical guidelines integrating extended genotyping would increase diagnostic accuracy and refine strategies in clinical management.
在宫颈鳞状和腺体病变中,已经发现了一系列人类乳头瘤病毒(HPV)基因型。本综述旨在利用组织学和细胞学研究结果,全面总结宫颈病变中检测到的 HPV 基因型的分布和特征。高危型 HPV(HR-HPV)基因型具有不同程度的致癌潜能,其中 HPV16 和 HPV18 被认为是最常见的致癌类型。HR-HPV 基因型的分布在不同程度的宫颈病变中各不相同,在鳞状和腺状肿瘤中也各不相同。HPV16 主要与严重病变(癌前病变和癌)有关,而 HPV18 在宫颈内膜的发病率明显高于鳞状肿瘤。HR-HPV 在重度鳞状病变中的分布很复杂,除 HPV16 外还涉及多种 HR-HPV 基因型,而 HR-HPV 基因型在宫颈内膜腺体病变中的分布主要局限于 HPV18 和 HPV16。来自中国的大型数据集按诊断类别分层确定了该人群中三种最常见的 HR-HPV 基因型:组织学阴性病例和宫颈上皮内瘤变 1(CIN1)中的 HPV52、HPV16、HPV58;CIN2/3 中的 HPV16、HPV52、HPV58;鳞状细胞癌(SCC)中的 HPV16、HPV58、HPV52 或 HPV18;宫颈内膜原位腺癌(AIS)、浸润性腺癌以及鳞状和腺状混合病变中的 HPV16、HPV18 和 HPV52。HPV33 是 CIN2/3 和 SCC 中第四种最常见的 HPV 类型,而与鳞状病变相比,HPV45 在 AIS 和腺癌中更常见。在不同的宫颈疾病中,多种 HR-HPV 合并感染的发生率和分布情况各不相同。尽管最近的两项大型研究表明,多重 HR-HPV 感染与高级别宫颈鳞状病变的累积高风险无关,但这些多重 HR-HPV 感染的临床意义和发病机制仍不确定,这表明 HPV 基因型之间存在竞争和/或合作性相互作用。广泛的 HPV 基因分型有助于对巴氏细胞学轻度异常的妇女进行风险评估和优化临床方法。宫颈细胞学检查结果为非典型鳞状细胞(ASC-US)和低级别鳞状上皮内病变(LSIL)的妇女,如果感染了某些 HR-HPV 基因型,发生高级别宫颈病变的风险很低。HPV 基因分型可以对这些 HR-HPV 阳性女性进行风险分层和分流优化。非典型腺细胞(AGC)巴氏试验结果显示了特定的 HPV 基因分型模式,扩大 HPV 基因分型可能有助于 AGC 的临床管理。临床指南的不断进步与扩展基因分型的结合将提高诊断的准确性并完善临床管理策略。
{"title":"Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions","authors":"Yuhong Ye, Terrel Jones, Tiannan Wang, Xianxu Zeng, Yang Liu, Chengquan Zhao","doi":"10.1136/gocm-2024-000005","DOIUrl":"https://doi.org/10.1136/gocm-2024-000005","url":null,"abstract":"Across cervical squamous and glandular lesions, a spectrum of human papillomavirus (HPV) genotypes has been identified. This review aims to provide a comprehensive summary detailing the distribution and profile of HPV genotypes detected in cervical lesions, leveraging insights from histological and cytological findings. High-risk HPV (HR-HPV) genotypes exhibit varying degrees of oncogenic potential, with HPV16 and HPV18 identified as the most prevalent and oncogenic types. The distribution of HR-HPV genotypes varies among different degrees of the cervical lesions and varies between squamous and glandular neoplasia. HPV16 is predominantly associated with severe lesions (precancers and carcinomas), while HPV18 demonstrates a significantly higher prevalence in endocervical as compared with squamous neoplasia. The distribution of HR-HPV in severe squamous lesions is complex, involving many HR-HPV genotypes in addition to HPV16, while the distribution of HR-HPV genotypes in endocervical glandular lesions is mainly limited in HPV18 and HPV16. Large datasets from China have identified the three most common HR-HPV genotypes in this population as stratified by diagnostic category: HPV52, HPV16, HPV58 in histologically negative cases and cervical intraepithelial neoplasia 1 (CIN1); HPV16, HPV52, HPV58 in CIN2/3; HPV16, HPV58, HPV52 or HPV18 in squamous cell carcinoma (SCC); HPV16, HPV18 and HPV52 in endocervical adenocarcinoma in situ (AIS), invasive adenocarcinoma, as well as mixed squamous and glandular lesions. HPV33 is the fourth most common HPV type in CIN2/3 and SCC, while HPV45 occurs more commonly in AIS and adenocarcinoma, compared with squamous lesions. The prevalence and distribution of multiple HR-HPV coinfections vary across different cervical diseases. The clinical significance and pathogenesis of these multiple HR-HPV infections remain uncertain, although recent two large studies demonstrate that multiple HR-HPV infections are not associated with cumulatively higher risk of high-grade cervical squamous lesion development, suggesting competitive and/or cooperative interactions among HPV genotypes. Extensive HPV genotyping aids in risk assessment and optimising clinical approaches for women with mild abnormalities in Pap cytology. Women with atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) Pap test results and with the infection of some HR-HPV genotypes carry a very low risk of high-grade cervical lesions. HPV genotyping can allow for risk stratification and triage optimisation for these HR-HPV-positive women. Women with atypical glandular cell (AGC) Pap test results showed a specific HPV genotyping pattern and extended HPV genotyping may be helpful for the clinical management of AGCs. Continual advancements in clinical guidelines integrating extended genotyping would increase diagnostic accuracy and refine strategies in clinical management.","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"46 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140771284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does cesarean section prevent adverse neonatal outcomes associated with meconium amniotic fluid? 剖宫产能否预防羊水蜕膜引起的新生儿不良结局?
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.09.001
Amene Ranjbar , Sepideh Rezaei Ghamsari , Elham Taeidi , Vahid Mehrnoush , Fatemeh Darsareh

Background

Making decisions regarding the mode of delivery in the cases of meconium amniotic fluid (MAF) presents a challenge for healthcare providers. We aimed to compare the neonatal outcome of MAF cases delivered via cesarean section (CS) versus those delivered vaginally to determine if CS is a protective factor against the adverse neonatal outcomes.

Methods

In this retrospective study, we assessed singleton pregnant mothers diagnosed with MAF who gave birth at a tertiary hospital in Bandar Abbas, Iran, between January 2020-2022. Mothers with certain adverse pregnancy conditions were excluded from the study. These conditions included: abnormal fetal heart rate and pattern, bloody amniotic fluid, malpresentation, abnormal placentation, chorioamnionitis, intrauterine growth restriction, intrauterine fetal death, obstructed labor, and maternal comorbidities. The MAF mothers were divided into two groups based on the method of delivery: those who had CS and those who had a normal vaginal delivery (NVD). Demographic factors, obstetrical factors, and neonatal outcomes were compared between the two groups.

Results

Out of 746 MAF mothers, 213 (28.5%) underwent CS, while 533 (71.4%) had NVD. There were no significant differences between the groups in terms of demographic characteristics. Among MAF mothers who had CS, 66.2% were primiparous, and 33.8% were multiparous. For those who had NVD, 35.1% were primiparous, and 64.9% were multiparous. The first and 5-min Apgar values, rates of asphyxia, neonatal intensive care unit (NICU) admission, and neonatal death were not statistically different between the two delivery modes. The rate of newborns who breastfed within the first hour did not differ depending on the mode of delivery. Although initial resuscitation steps were required more frequently in MAF mothers with NVD than in those with CS (11.1% vs. 2.3%), no correlation was found between the mode of delivery and the need for resuscitation using logistic regression.

Conclusions

Our research findings suggest that there were no superior neonatal outcomes in terms of CS compared to NVD in MAF mothers. Further studies are needed to provide more substantial evidence to support this conclusion.

背景对于医护人员来说,在出现羊水过多(MAF)的情况下决定分娩方式是一项挑战。在这项回顾性研究中,我们对 2020 年 1 月至 2022 年 1 月期间在伊朗 Bandar Abbas 一家三级医院分娩的确诊为羊水过多症的单胎孕妇进行了评估。患有某些不良妊娠情况的母亲被排除在研究之外。这些情况包括:胎心率和胎型异常、血性羊水、胎位不正、胎盘异常、绒毛膜羊膜炎、胎儿宫内生长受限、胎儿宫内死亡、难产和产妇合并症。MAF产妇根据分娩方式分为两组:CS产妇和阴道正常分娩(NVD)产妇。结果 在 746 名 MAF 母亲中,213 人(28.5%)进行了 CS 分娩,533 人(71.4%)进行了 NVD 分娩。两组在人口统计学特征方面无明显差异。在进行CS的MAF母亲中,66.2%为初产妇,33.8%为多产妇。在进行 NVD 的产妇中,35.1% 为初产妇,64.9% 为多产妇。两种分娩方式的第一和5分钟Apgar值、窒息率、新生儿重症监护室入院率和新生儿死亡率没有统计学差异。在第一小时内进行母乳喂养的新生儿比率在分娩方式上没有差异。结论我们的研究结果表明,在 MAF 母亲中,CS 与 NVD 相比,新生儿结局并无优势。我们的研究结果表明,与 NVD 相比,CS 对 MAF 母亲的新生儿预后没有优势。
{"title":"Does cesarean section prevent adverse neonatal outcomes associated with meconium amniotic fluid?","authors":"Amene Ranjbar ,&nbsp;Sepideh Rezaei Ghamsari ,&nbsp;Elham Taeidi ,&nbsp;Vahid Mehrnoush ,&nbsp;Fatemeh Darsareh","doi":"10.1016/j.gocm.2023.09.001","DOIUrl":"10.1016/j.gocm.2023.09.001","url":null,"abstract":"<div><h3>Background</h3><p>Making decisions regarding the mode of delivery in the cases of meconium amniotic fluid (MAF) presents a challenge for healthcare providers. We aimed to compare the neonatal outcome of MAF cases delivered via cesarean section (CS) versus those delivered vaginally to determine if CS is a protective factor against the adverse neonatal outcomes.</p></div><div><h3>Methods</h3><p>In this retrospective study, we assessed singleton pregnant mothers diagnosed with MAF who gave birth at a tertiary hospital in Bandar Abbas, Iran, between January 2020-2022. Mothers with certain adverse pregnancy conditions were excluded from the study. These conditions included: abnormal fetal heart rate and pattern, bloody amniotic fluid, malpresentation, abnormal placentation, chorioamnionitis, intrauterine growth restriction, intrauterine fetal death, obstructed labor, and maternal comorbidities. The MAF mothers were divided into two groups based on the method of delivery: those who had CS and those who had a normal vaginal delivery (NVD). Demographic factors, obstetrical factors, and neonatal outcomes were compared between the two groups.</p></div><div><h3>Results</h3><p>Out of 746 MAF mothers, 213 (28.5%) underwent CS, while 533 (71.4%) had NVD. There were no significant differences between the groups in terms of demographic characteristics. Among MAF mothers who had CS, 66.2% were primiparous, and 33.8% were multiparous. For those who had NVD, 35.1% were primiparous, and 64.9% were multiparous. The first and 5-min Apgar values, rates of asphyxia, neonatal intensive care unit (NICU) admission, and neonatal death were not statistically different between the two delivery modes. The rate of newborns who breastfed within the first hour did not differ depending on the mode of delivery. Although initial resuscitation steps were required more frequently in MAF mothers with NVD than in those with CS (11.1% vs. 2.3%), no correlation was found between the mode of delivery and the need for resuscitation using logistic regression.</p></div><div><h3>Conclusions</h3><p>Our research findings suggest that there were no superior neonatal outcomes in terms of CS compared to NVD in MAF mothers. Further studies are needed to provide more substantial evidence to support this conclusion.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 241-244"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164623000830/pdfft?md5=53debc1b8f8317a6660d1daf74ccba7f&pid=1-s2.0-S2667164623000830-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135349457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A simplified method for evaluating the anatomical axis of the upper two-thirds of the vagina on MRI: A hospital-based cross-sectional study 磁共振成像评估阴道上三分之二解剖轴的简化方法:一项基于医院的横断面研究
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.10.003
Yinluan OuYang , Fan Li , Rui Wang , Wanwan Xu , Weizeng Zheng , Weijia Ying , Xiaofeng Zhao

Backgrounds

Pelvic organ prolapse commonly affects the upper two-thirds of the vagina. However, evaluating this region in its normal position presents challenges. This study aimed to assess the anatomical axis of this vaginal segment using pelvic magnetic resonance imaging measurements.

Methods

A retrospective study of 614 hospitalized women from two hospitals, who were rigorously screened to exclude those with Pelvic Organ Prolapse or known anatomical variations (median age: 43 years, range: 17–76 years). Two reference lines were used: the pubococcygeal line (PCL) and a line from the inferior pubic symphysis to the third sacral vertebra (PS3L). Distances between the distal, middle, and apical points of the upper vagina and the reference lines, as well as the angles between the upper vagina and the reference lines, were measured. Comparisons were made among different age groups.

Results

The median distances from the distal, middle, and apical vaginal points to the PCL were 0.4 ​cm (interquartile range [IQR]: 0.0–0.7 ​cm), 2.1 ​cm (IQR: 1.7–2.5 ​cm) and 3.1 ​cm (IQR: 2.5–3.7 ​cm), respectively. The median PCL-vaginal angle was 29.0° (IQR: 23.0–34.0°). The median distances from the distal, middle, and apical vaginal points to the PS3L were -0.5 ​cm (IQR: -0.9–0.0 ​cm), 0.0 ​cm (IQR: -0.4–0.6 ​cm), and -0.2 ​cm (IQR: -0.9– 0.0 ​cm), respectively. The median PS3L-vaginal angle was 0.0° (IQR: -4.0–7.0°). Women aged 50 years or older had slightly lower vaginal points and slightly larger angles than younger groups in relation to both reference lines (p ​< ​.001). The vaginal axis in younger groups appeared parallel to the PS3L.

Conclusions

The axis of the upper two-thirds vagina was proximate to a line from the inferior pubic symphysis to the third sacral vertebra, particularly in younger women. It will likely become a simplified method for roughly assessing the vaginal axis in its situ at first glance.

背景盆腔器官脱垂通常影响阴道的上三分之二。然而,评估该区域的正常位置是一项挑战。方法对两家医院的 614 名住院妇女进行回顾性研究,严格筛选以排除盆腔器官脱垂或已知解剖变异的妇女(中位年龄:43 岁,范围:17-76 岁)。使用了两条参考线:耻骨尾骨线(PCL)和从耻骨联合下端到第三骶椎(PS3L)的一条线。测量了上阴道远端、中间和顶端点与参考线之间的距离,以及上阴道与参考线之间的角度。结果 阴道远端、中间和顶端点到 PCL 的中位距离分别为 0.4 厘米(四分位间距 [IQR]:0.0-0.7 厘米)、2.1 厘米(IQR:1.7-2.5 厘米)和 3.1 厘米(IQR:2.5-3.7 厘米)。PCL 与阴道夹角的中位数为 29.0°(IQR:23.0-34.0°)。阴道远端、中间和顶端点到 PS3L 的中位距离分别为-0.5 厘米(IQR:-0.9-0.0 厘米)、0.0 厘米(IQR:-0.4-0.6 厘米)和-0.2 厘米(IQR:-0.9- 0.0 厘米)。PS3L 与阴道夹角的中位数为 0.0°(IQR:-4.0-7.0°)。与两条参考线相比,50 岁或以上妇女的阴道点略低,角度略大于年轻组(p < .001)。结论上三分之二阴道的轴线靠近从耻骨联合下缘到第三骶椎的一条线,尤其是在年轻女性中。这可能会成为粗略评估阴道轴线原位的简化方法。
{"title":"A simplified method for evaluating the anatomical axis of the upper two-thirds of the vagina on MRI: A hospital-based cross-sectional study","authors":"Yinluan OuYang ,&nbsp;Fan Li ,&nbsp;Rui Wang ,&nbsp;Wanwan Xu ,&nbsp;Weizeng Zheng ,&nbsp;Weijia Ying ,&nbsp;Xiaofeng Zhao","doi":"10.1016/j.gocm.2023.10.003","DOIUrl":"10.1016/j.gocm.2023.10.003","url":null,"abstract":"<div><h3>Backgrounds</h3><p>Pelvic organ prolapse commonly affects the upper two-thirds of the vagina. However, evaluating this region in its normal position presents challenges. This study aimed to assess the anatomical axis of this vaginal segment using pelvic magnetic resonance imaging measurements.</p></div><div><h3>Methods</h3><p>A retrospective study of 614 hospitalized women from two hospitals, who were rigorously screened to exclude those with Pelvic Organ Prolapse or known anatomical variations (median age: 43 years, range: 17–76 years). Two reference lines were used: the pubococcygeal line (PCL) and a line from the inferior pubic symphysis to the third sacral vertebra (PS3L). Distances between the distal, middle, and apical points of the upper vagina and the reference lines, as well as the angles between the upper vagina and the reference lines, were measured. Comparisons were made among different age groups.</p></div><div><h3>Results</h3><p>The median distances from the distal, middle, and apical vaginal points to the PCL were 0.4 ​cm (interquartile range [IQR]: 0.0–0.7 ​cm), 2.1 ​cm (IQR: 1.7–2.5 ​cm) and 3.1 ​cm (IQR: 2.5–3.7 ​cm), respectively. The median PCL-vaginal angle was 29.0° (IQR: 23.0–34.0°). The median distances from the distal, middle, and apical vaginal points to the PS3L were -0.5 ​cm (IQR: -0.9–0.0 ​cm), 0.0 ​cm (IQR: -0.4–0.6 ​cm), and -0.2 ​cm (IQR: -0.9– 0.0 ​cm), respectively. The median PS3L-vaginal angle was 0.0° (IQR: -4.0–7.0°). Women aged 50 years or older had slightly lower vaginal points and slightly larger angles than younger groups in relation to both reference lines (p ​&lt; ​.001). The vaginal axis in younger groups appeared parallel to the PS3L.</p></div><div><h3>Conclusions</h3><p>The axis of the upper two-thirds vagina was proximate to a line from the inferior pubic symphysis to the third sacral vertebra, particularly in younger women. It will likely become a simplified method for roughly assessing the vaginal axis in its situ at first glance.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 229-235"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164623000878/pdfft?md5=606c5b044b9a64bae1b9dcac0dc29cb1&pid=1-s2.0-S2667164623000878-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135614356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidelines for cervical cancer screening in China 中国宫颈癌筛查指南
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.10.005
Mingzhu Li , Lihui Wei , Long Sui , Ding Ma , Beihua Kong , Xiaohua Wu , Peng Wu , Youlin Qiao , Fanghui Zhao , Linhong Wang

In response to the incidence of cervical intraepithelial neoplasia and cervical cancer in China and global screening strategies, a collaborative effort was undertaken by seven Chinese medical associations to develop this guideline for cervical cancer screening. The guideline recommends high-risk human papillomavirus (hr-HPV) testing as the preferred method for primary screening, which should have been approved by authoritative institutions and clinically validated for primary screening. In areas without access to HPV testing, cytology can be used as an alternative. However, it is recommended to replace cytology with HPV-based screening as conditions permit. Cotesting (HPV testing in combination with cytology) is recommended for areas with sufficient medical resources, opportunistic screening populations, and partial special populations. The guideline recommends that individuals with a cervix initiate cervical cancer screening at the age 25 years and undergo HPV testing alone or cotesting every five years, or cytology alone every three years. Women over the age of 65 who have had documented adequate negative prior screening in the past may terminate screening. Corresponding screening programs are proposed for different special populations. The development of these guidelines is an important step in the effort to eliminate cervical cancer in China.

针对中国宫颈上皮内瘤变和宫颈癌的发病情况和全球筛查策略,中国七个医学会合作制定了本宫颈癌筛查指南。指南推荐将高危人乳头瘤病毒(hr-HPV)检测作为初筛的首选方法,该方法应经权威机构批准并通过初筛临床验证。在无法进行人乳头瘤病毒检测的地区,可以使用细胞学作为替代方法。但建议在条件允许的情况下,用基于 HPV 的筛查取代细胞学检查。对于医疗资源充足的地区、机会性筛查人群和部分特殊人群,建议采用联合检测(HPV 检测与细胞学检查相结合)。该指南建议有宫颈的人在 25 岁时开始接受宫颈癌筛查,每五年进行一次单独的 HPV 检测或联合检测,或每三年进行一次单独的细胞学检测。65 岁以上的妇女,如果在过去的筛查中有足够的阴性记录,可以终止筛查。针对不同的特殊人群提出了相应的筛查方案。这些指南的制定是中国消除宫颈癌工作的重要一步。
{"title":"Guidelines for cervical cancer screening in China","authors":"Mingzhu Li ,&nbsp;Lihui Wei ,&nbsp;Long Sui ,&nbsp;Ding Ma ,&nbsp;Beihua Kong ,&nbsp;Xiaohua Wu ,&nbsp;Peng Wu ,&nbsp;Youlin Qiao ,&nbsp;Fanghui Zhao ,&nbsp;Linhong Wang","doi":"10.1016/j.gocm.2023.10.005","DOIUrl":"https://doi.org/10.1016/j.gocm.2023.10.005","url":null,"abstract":"<div><p>In response to the incidence of cervical intraepithelial neoplasia and cervical cancer in China and global screening strategies, a collaborative effort was undertaken by seven Chinese medical associations to develop this guideline for cervical cancer screening. The guideline recommends high-risk human papillomavirus (hr-HPV) testing as the preferred method for primary screening, which should have been approved by authoritative institutions and clinically validated for primary screening. In areas without access to HPV testing, cytology can be used as an alternative. However, it is recommended to replace cytology with HPV-based screening as conditions permit. Cotesting (HPV testing in combination with cytology) is recommended for areas with sufficient medical resources, opportunistic screening populations, and partial special populations. The guideline recommends that individuals with a cervix initiate cervical cancer screening at the age 25 years and undergo HPV testing alone or cotesting every five years, or cytology alone every three years. Women over the age of 65 who have had documented adequate negative prior screening in the past may terminate screening. Corresponding screening programs are proposed for different special populations. The development of these guidelines is an important step in the effort to eliminate cervical cancer in China.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 189-194"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164623000891/pdfft?md5=04be6b6602cd50480ffac3c4c43a38e6&pid=1-s2.0-S2667164623000891-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nursing discharge teaching of hospitalized postpartum women in China: A cross-sectional study 中国产后住院妇女的出院护理教学:横断面研究
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.11.001
Sen Li, Yan Liu, Guoli Liu

Background

Postpartum women encounter a diverse array of physiological challenges following childbirth, and they may also contend with issues such as a lack of self-care knowledge childcare knowledge, and childcare experience. This study aimed to explore the quality of discharge teaching for hospitalized postpartum women.

Methods

A total of 292 parturients who gave birth in a tertiary hospital were selected using the convenience sampling method and surveyed using a general data questionnaire and discharge teaching quality scale.

Results

The total score for the quality of discharge teaching was 111.95 ​± ​28.64. In bivariate analysis, significant differences were identified between postpartum women with differences in postpartum complications, ambulation time, wound pain, infant health status, and infant feeding methods (p ​< ​0.05). Wound pain and infant feeding methods were significant factors in a multiple linear regression model (p ​< ​0.05).

Conclusions

Nursing staff should focus on psychological nursing care and give more personalized teaching to postpartum women with severe wound pain and who bottle feed their newborns.

背景产后妇女在分娩后会遇到各种各样的生理挑战,她们还可能面临缺乏自我护理知识、育儿知识和育儿经验等问题。本研究旨在探讨住院产后妇女的出院指导质量。方法采用便利抽样法选取在某三级医院分娩的 292 名产妇,使用一般资料问卷和出院指导质量量表进行调查。在双变量分析中,发现产后妇女在产后并发症、行走时间、伤口疼痛、婴儿健康状况和婴儿喂养方式方面存在显著差异(P < 0.05)。在多元线性回归模型中,伤口疼痛和婴儿喂养方式是重要的影响因素(p <0.05)。结论护理人员应注重心理护理,对伤口疼痛严重、用奶瓶喂养新生儿的产后妇女给予更多个性化的指导。
{"title":"Nursing discharge teaching of hospitalized postpartum women in China: A cross-sectional study","authors":"Sen Li,&nbsp;Yan Liu,&nbsp;Guoli Liu","doi":"10.1016/j.gocm.2023.11.001","DOIUrl":"https://doi.org/10.1016/j.gocm.2023.11.001","url":null,"abstract":"<div><h3>Background</h3><p>Postpartum women encounter a diverse array of physiological challenges following childbirth, and they may also contend with issues such as a lack of self-care knowledge childcare knowledge, and childcare experience. This study aimed to explore the quality of discharge teaching for hospitalized postpartum women.</p></div><div><h3>Methods</h3><p>A total of 292 parturients who gave birth in a tertiary hospital were selected using the convenience sampling method and surveyed using a general data questionnaire and discharge teaching quality scale.</p></div><div><h3>Results</h3><p>The total score for the quality of discharge teaching was 111.95 ​± ​28.64. In bivariate analysis, significant differences were identified between postpartum women with differences in postpartum complications, ambulation time, wound pain, infant health status, and infant feeding methods (<em>p</em> ​&lt; ​0.05). Wound pain and infant feeding methods were significant factors in a multiple linear regression model (<em>p</em> ​&lt; ​0.05).</p></div><div><h3>Conclusions</h3><p>Nursing staff should focus on psychological nursing care and give more personalized teaching to postpartum women with severe wound pain and who bottle feed their newborns.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 236-240"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164623000908/pdfft?md5=0fa461457c54cc68525ca61520422892&pid=1-s2.0-S2667164623000908-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in ablative treatment for human papillomavirus related cervical pre-cancer lesions 人类乳头瘤病毒相关宫颈癌前病变消融治疗的进展
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.11.002
Lili Xu, Yanming Jiang, Renfeng Zhao

HPV infection is the primary cause of cervical intraepithelial neoplasia (CIN), with persistent high-risk HPV infection being the leading factor in the development of cervical cancer. In addition to the application of large loop excision of the transformation zone (LLETZ) for the treatment of cervical pre-cancerous lesions, various ablative techniques, including thermal ablation, cryotherapy, carbon dioxide (CO2) laser therapy, and focused ultrasound therapy also play significant roles in the management of cervical intraepithelial neoplasia. This review presents a comprehensive overview of the pathophysiology of cervical HPV infection and discusses the ablative methods commonly used in clinical practice, along with their indication and contradiction, especially in women with high-grade squamous intraepithelial lesions. The aim is to identify safe and effective treatment strategies for treating cervical intraepithelial neoplasia, thereby avoiding under- or over-treatment, which may reduce the incidence and progression of cervical cancer through timely diagnosis and treatment.

人乳头瘤病毒(HPV)感染是宫颈上皮内瘤变(CIN)的主要病因,高危 HPV 持续感染是宫颈癌发病的主要因素。除了应用转化区大环切除术(LLETZ)治疗宫颈癌前病变外,各种消融技术,包括热消融、冷冻治疗、二氧化碳(CO2)激光治疗和聚焦超声治疗也在宫颈上皮内瘤变的治疗中发挥着重要作用。本综述全面概述了宫颈 HPV 感染的病理生理学,并讨论了临床实践中常用的消融方法及其适应症和矛盾之处,尤其是在患有高级别鳞状上皮内病变的妇女中。目的是找出安全有效的治疗宫颈上皮内瘤变的治疗策略,从而避免治疗不足或治疗过度,通过及时诊断和治疗减少宫颈癌的发病率和恶化。
{"title":"Advances in ablative treatment for human papillomavirus related cervical pre-cancer lesions","authors":"Lili Xu,&nbsp;Yanming Jiang,&nbsp;Renfeng Zhao","doi":"10.1016/j.gocm.2023.11.002","DOIUrl":"https://doi.org/10.1016/j.gocm.2023.11.002","url":null,"abstract":"<div><p>HPV infection is the primary cause of cervical intraepithelial neoplasia (CIN), with persistent high-risk HPV infection being the leading factor in the development of cervical cancer. In addition to the application of large loop excision of the transformation zone (LLETZ) for the treatment of cervical pre-cancerous lesions, various ablative techniques, including thermal ablation, cryotherapy, carbon dioxide (CO<sub>2</sub>) laser therapy, and focused ultrasound therapy also play significant roles in the management of cervical intraepithelial neoplasia. This review presents a comprehensive overview of the pathophysiology of cervical HPV infection and discusses the ablative methods commonly used in clinical practice, along with their indication and contradiction, especially in women with high-grade squamous intraepithelial lesions. The aim is to identify safe and effective treatment strategies for treating cervical intraepithelial neoplasia, thereby avoiding under- or over-treatment, which may reduce the incidence and progression of cervical cancer through timely diagnosis and treatment.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 213-219"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266716462300091X/pdfft?md5=0517e8c8b31a02790fdfaae116b943bc&pid=1-s2.0-S266716462300091X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retroperitoneal para-aortic ectopic pregnancies: A review of reported cases 腹膜后主动脉旁异位妊娠:报告病例回顾
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.10.004
Junxiang Ren, Hongjing Han

Objective

To gain insights into the diagnosis and treatment of retroperitoneal para-aortic ectopic pregnancies (RPEP).

Methods

We conducted a review of the existing literature from the web of science, PubMed, and CNKI using the search terms "ectopic pregnancy" and "retroperitoneal." The present review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.

Results

After applying the inclusion and exclusion criteria, we included a total of 54 relevant works, encompassing 55 cases. The studies have revealed that a history of artificial abortion, embryo transfer, salpingectomy, and uterine cavity operation, accounted for 65.5 ​% (36/55) of the cases. Typical symptoms of RPEP include abdominal pain (43.6 ​%, 24/55) and vaginal bleeding (36.4 ​%, 20/55), with only 32.7 ​% (18/55) of cases being asymptomatic. The most common sites of RPEP are the abdominal aorta and the inferior vena cava (74.5 ​%, 41/55). There were no statistically significant differences in the incidence of acute abdomen, diameter of the pregnancy sac, number of surgeries, and the time for postoperative hCG to normalize in different pregnant site. The most effective imaging examination for RPEP was found to be abdominal ultrasound (72.7 ​%, 40/55), and the most commonly used treatment method was laparoscopy surgery (55.3 ​% ,21/38).

Conclusion

It is crucial to consider the possibility of RPEP when a pregnancy mass cannot be located during routine examinations. Expanding the scope of the scan may significantly expedite diagnosis and treatment.

方法 我们以 "异位妊娠 "和 "腹膜后 "为检索词,对科学网、PubMed 和 CNKI 上的现有文献进行了综述。本综述遵循系统综述和荟萃分析首选报告项目(PRISMA)指南。结果在应用纳入和排除标准后,我们共纳入了 54 篇相关文献,包括 55 个病例。研究显示,有人工流产史、胚胎移植史、输卵管切除术史和子宫腔手术史的病例占 65.5%(36/55)。RPEP 的典型症状包括腹痛(43.6%,24/55)和阴道出血(36.4%,20/55),只有 32.7%(18/55)的病例无症状。RPEP 最常见的部位是腹主动脉和下腔静脉(74.5%,41/55)。不同妊娠部位的急腹症发生率、孕囊直径、手术次数和术后 hCG 恢复正常的时间均无统计学差异。RPEP最有效的影像学检查是腹部超声(72.7%,40/55),最常用的治疗方法是腹腔镜手术(55.3%,21/38)。扩大扫描范围可大大加快诊断和治疗。
{"title":"Retroperitoneal para-aortic ectopic pregnancies: A review of reported cases","authors":"Junxiang Ren,&nbsp;Hongjing Han","doi":"10.1016/j.gocm.2023.10.004","DOIUrl":"https://doi.org/10.1016/j.gocm.2023.10.004","url":null,"abstract":"<div><h3>Objective</h3><p>To gain insights into the diagnosis and treatment of retroperitoneal para-aortic ectopic pregnancies (RPEP).</p></div><div><h3>Methods</h3><p>We conducted a review of the existing literature from the web of science, PubMed, and CNKI using the search terms \"ectopic pregnancy\" and \"retroperitoneal.\" The present review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.</p></div><div><h3>Results</h3><p>After applying the inclusion and exclusion criteria, we included a total of 54 relevant works, encompassing 55 cases. The studies have revealed that a history of artificial abortion, embryo transfer, salpingectomy, and uterine cavity operation, accounted for 65.5 ​% (36/55) of the cases. Typical symptoms of RPEP include abdominal pain (43.6 ​%, 24/55) and vaginal bleeding (36.4 ​%, 20/55), with only 32.7 ​% (18/55) of cases being asymptomatic. The most common sites of RPEP are the abdominal aorta and the inferior vena cava (74.5 ​%, 41/55). There were no statistically significant differences in the incidence of acute abdomen, diameter of the pregnancy sac, number of surgeries, and the time for postoperative hCG to normalize in different pregnant site. The most effective imaging examination for RPEP was found to be abdominal ultrasound (72.7 ​%, 40/55), and the most commonly used treatment method was laparoscopy surgery (55.3 ​% ,21/38).</p></div><div><h3>Conclusion</h3><p>It is crucial to consider the possibility of RPEP when a pregnancy mass cannot be located during routine examinations. Expanding the scope of the scan may significantly expedite diagnosis and treatment.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 220-228"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266716462300088X/pdfft?md5=ebb2647ff7ed3578546c1f480f01d267&pid=1-s2.0-S266716462300088X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selective applications of excisional surgical treatments of cervical precancers 宫颈癌前病变切除手术治疗的选择性应用
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.11.003
Minxia Wu, Zhixue You

Cervical precancers encompass high-grade squamous intraepithelial lesion and adenocarcinoma in situ. Treatment of precancerous lesions can reduce cervical cancer mortality and prevent the development of invasive cervical cancer. The choice of treatment regimen needs to follow the principle of individualization and should be based on a combination of factors, including the patient's age, fertility requirements, pregnancy status, pathological type, type of colposcopic transformation zone, patient's follow-up conditions, and the experience of the treating provider. This article presents an opinion regarding the appropriate indications for excisional surgery and total hysterectomy in the management of precancerous lesions of the cervix, with the aim of establishing standardized therapeutic approaches for the treatment of precancerous lesions of the cervix.

宫颈癌前病变包括高级别鳞状上皮内病变和原位腺癌。治疗癌前病变可以降低宫颈癌的死亡率,预防浸润性宫颈癌的发生。治疗方案的选择需要遵循个体化原则,应根据患者的年龄、生育要求、妊娠状况、病理类型、阴道镜下转化区的类型、患者的随访情况以及治疗者的经验等综合因素进行选择。本文就宫颈癌前病变治疗中切除手术和全子宫切除术的适当适应症提出了自己的看法,旨在为宫颈癌前病变的治疗建立标准化的治疗方法。
{"title":"Selective applications of excisional surgical treatments of cervical precancers","authors":"Minxia Wu,&nbsp;Zhixue You","doi":"10.1016/j.gocm.2023.11.003","DOIUrl":"10.1016/j.gocm.2023.11.003","url":null,"abstract":"<div><p>Cervical precancers encompass high-grade squamous intraepithelial lesion and adenocarcinoma in situ. Treatment of precancerous lesions can reduce cervical cancer mortality and prevent the development of invasive cervical cancer. The choice of treatment regimen needs to follow the principle of individualization and should be based on a combination of factors, including the patient's age, fertility requirements, pregnancy status, pathological type, type of colposcopic transformation zone, patient's follow-up conditions, and the experience of the treating provider. This article presents an opinion regarding the appropriate indications for excisional surgery and total hysterectomy in the management of precancerous lesions of the cervix, with the aim of establishing standardized therapeutic approaches for the treatment of precancerous lesions of the cervix.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 198-202"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164623001057/pdfft?md5=740431658c4aa34d98396908c7082d44&pid=1-s2.0-S2667164623001057-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138620625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical significance of human papillomavirus and p16INK4a in vulvar tumors 外阴肿瘤中人类乳头瘤病毒和 p16INK4a 的临床意义
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.10.001
Penglin Liu , Zhuang Li , Zhongshao Chen , Zhaoyang Zhang , Kun Song , Jinwei Miao , Beihua Kong
{"title":"The clinical significance of human papillomavirus and p16INK4a in vulvar tumors","authors":"Penglin Liu ,&nbsp;Zhuang Li ,&nbsp;Zhongshao Chen ,&nbsp;Zhaoyang Zhang ,&nbsp;Kun Song ,&nbsp;Jinwei Miao ,&nbsp;Beihua Kong","doi":"10.1016/j.gocm.2023.10.001","DOIUrl":"10.1016/j.gocm.2023.10.001","url":null,"abstract":"","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 195-197"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164623000854/pdfft?md5=9d5474ef2f0b7302638e010423ce0410&pid=1-s2.0-S2667164623000854-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135614978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trichomonas vaginalis and human papillomavirus: Association with the microbiota and burden on the cervix 阴道毛滴虫和人类乳头瘤病毒:与微生物群和宫颈负担的关系
Q4 Medicine Pub Date : 2023-12-01 DOI: 10.1016/j.gocm.2023.10.002
Kelvin Stefan Osafo , Wenyu Lin , Binhua Dong , Pengming Sun

Trichomoniasis and HPV infection are common non-viral and viral sexually transmitted diseases worldwide. Emerging evidence shows that the female genital tract and its microbiota are greatly affected by these pathogens. However, the relationship between Trichomonas vaginalis, the vaginal microbiome, and High-risk (HR)-HPV infection is complex and multifaceted. Studies have proven that concurrent infections of HIV and HPV increase the risk of cervical cancer. With this basis, a question arises: How does the concurrent infection of trichomonas vaginalis and HPV affect genital tract health? Does this concurrent infection enhance or inhibit the development of cervical lesions? This review aims to bring light to these questions. This review also covers the association of trichomonas vaginalis and HPV with the microbiota of the genital tract.

滴虫病和人乳头瘤病毒感染是全球常见的非病毒性和病毒性性传播疾病。新的证据表明,女性生殖道及其微生物群受到这些病原体的极大影响。然而,阴道毛滴虫、阴道微生物群和高危(HR)-HPV 感染之间的关系是复杂和多方面的。研究证明,同时感染 HIV 和 HPV 会增加罹患宫颈癌的风险。在此基础上,就产生了一个问题:同时感染阴道毛滴虫和 HPV 对生殖道健康有何影响?同时感染会增强还是抑制宫颈病变的发展?本综述旨在揭示这些问题。本综述还涉及阴道毛滴虫和人乳头瘤病毒与生殖道微生物群的关系。
{"title":"Trichomonas vaginalis and human papillomavirus: Association with the microbiota and burden on the cervix","authors":"Kelvin Stefan Osafo ,&nbsp;Wenyu Lin ,&nbsp;Binhua Dong ,&nbsp;Pengming Sun","doi":"10.1016/j.gocm.2023.10.002","DOIUrl":"10.1016/j.gocm.2023.10.002","url":null,"abstract":"<div><p>Trichomoniasis and HPV infection are common non-viral and viral sexually transmitted diseases worldwide. Emerging evidence shows that the female genital tract and its microbiota are greatly affected by these pathogens. However, the relationship between Trichomonas vaginalis, the vaginal microbiome, and High-risk (HR)-HPV infection is complex and multifaceted. Studies have proven that concurrent infections of HIV and HPV increase the risk of cervical cancer. With this basis, a question arises: How does the concurrent infection of trichomonas vaginalis and HPV affect genital tract health? Does this concurrent infection enhance or inhibit the development of cervical lesions? This review aims to bring light to these questions. This review also covers the association of trichomonas vaginalis and HPV with the microbiota of the genital tract.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 4","pages":"Pages 207-212"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164623000866/pdfft?md5=83a14537cd716f3fd161006934c686de&pid=1-s2.0-S2667164623000866-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135615183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gynecology and Obstetrics Clinical Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1